Oncolys
4588.TOncolys BioPharma Inc. Price (4588.T)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
21,831,246
(22.6656)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Oncolys BioPharma Inc.Currency: JPY
| YEAR | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
396,754,000.00
+0% |
1,180,000.00
-100% |
28,797,000.00
+2,340% |
121,303,000.00
+321% |
178,313,000.00
+47% |
229,139,000.00
+29% |
168,549,000.00
-26% |
1,303,844,000.00
+674% |
314,179,000.00
-76% |
642,494,000.00
+104% |
976,182,000.00
+52% |
63,038,000.00
-94% |
31,384,000.00
-50% |
||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 0.00 | 40,000.00 | 394,000.00 | 16,000.00 | 16,000.00 | 71,557,000.00 | 121,331,000.00 | 112,900,000.00 | 78,065,000.00 | 443,690,000.00 | 637,695,000.00 | 32,433,000.00 | 0.00 | ||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
396,754,000.00
+0% |
1,140,000.00
-100% |
28,403,000.00
+2,391% |
121,287,000.00
+327% |
178,297,000.00
+47% |
157,582,000.00
-12% |
47,218,000.00
-70% |
1,190,944,000.00
+2,422% |
236,114,000.00
-80% |
198,804,000.00
-16% |
338,487,000.00
+70% |
30,605,000.00
-91% |
31,384,000.00
+3% |
||||||
| Gross Profit Ratio | (1.00%) | (0.97%) | (0.99%) | (1.00%) | (1.00%) | (0.69%) | (0.28%) | (0.91%) | (0.75%) | (0.31%) | (0.35%) | (0.49%) | (1.00%) | ||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 0.00 | 0.00 | 0.00 | 552,741,000.00 | 360,869,000.00 | 570,541,000.00 | 605,822,000.00 | 562,694,000.00 | 987,242,000.00 | 825,474,000.00 | 947,491,000.00 | 1,351,940,000.00 | 1,088,997,000.00 | ||||||
| General and Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Selling, General & Admin... | 0.00 | 0.00 | 0.00 | 502,999,000.00 | 663,017,000.00 | 599,115,000.00 | 625,402,000.00 | 1,072,614,000.00 | 877,984,000.00 | 725,938,000.00 | 574,640,000.00 | 0.00 | 1,718,992,000.00 | ||||||
| Selling & Marketing Exp... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Depreciation and Amortiz... | 16,953,000.00 | 17,139,000.00 | 12,551,000.00 | 16,764,000.00 | 15,722,000.00 | 1,520,000.00 | 2,067,000.00 | 3,109,000.00 | 4,890,000.00 | 6,486,000.00 | 914,000.00 | 2,286,000.00 | 815,000.00 | ||||||
| Other Expenses | 2,910,000.00 | 39,587,000.00 | 98,050,000.00 | 99,008,000.00 | 303,000.00 | 29,000.00 | 30,000.00 | 1,702,406,000.00 | 1,910,766,000.00 | 1,653,357,000.00 | 1,542,993,000.00 | 608,651,000.00 | -1,095,202,000.00 | ||||||
| Total Operating Expenses | 537,709,000.00 | 666,601,000.00 | 856,148,000.00 | 1,072,862,000.00 | 1,039,608,000.00 | 1,235,970,000.00 | 1,294,781,000.00 | 1,702,406,000.00 | 1,910,766,000.00 | 1,653,357,000.00 | 1,542,993,000.00 | 1,960,591,000.00 | 1,712,787,000.00 | ||||||
| Cost and Exponses | 537,709,000.00 | 666,641,000.00 | 856,542,000.00 | 1,072,878,000.00 | 1,039,624,000.00 | 1,307,527,000.00 | 1,416,112,000.00 | 1,815,306,000.00 | 1,988,831,000.00 | 2,097,047,000.00 | 2,180,688,000.00 | 1,993,024,000.00 | 1,712,787,000.00 | ||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
-140,954,000.00
+0% |
-665,462,000.00
+372% |
-827,744,000.00
+24% |
-951,575,000.00
+15% |
-861,311,000.00
-9% |
-1,078,389,000.00
+25% |
-1,247,563,000.00
+16% |
-511,463,000.00
-59% |
-1,674,653,000.00
+227% |
-1,454,554,000.00
-13% |
-1,204,506,000.00
-17% |
-1,929,986,000.00
+60% |
-1,681,403,000.00
-13% |
||||||
| Operating Income Ratio | (-0.36%) | (-563.95%) | (-28.74%) | (-7.84%) | (-4.83%) | (-4.71%) | (-7.40%) | (-0.39%) | (-5.33%) | (-2.26%) | (-1.23%) | (-30.62%) | (-53.58%) | ||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 958,000.00 | 883,000.00 | 2,906,000.00 | 3,587,000.00 | 4,894,000.00 | 3,887,000.00 | 21,380,000.00 | 20,235,000.00 | 565,000.00 | 494,000.00 | 587,000.00 | 1,475,000.00 | 0.00 | ||||||
| Interest Expenses | 8,345,000.00 | 2,839,000.00 | 4,943,000.00 | 4,244,000.00 | 3,221,000.00 | 3,274,000.00 | 2,797,000.00 | 3,947,000.00 | 4,170,000.00 | 4,169,000.00 | 3,945,000.00 | 3,602,000.00 | 0.00 | ||||||
| Total Other Income/Exp... | 40,441,000.00 | 32,269,000.00 | 90,638,000.00 | 96,874,000.00 | -67,033,000.00 | -8,796,000.00 | 17,458,000.00 | -397,130,000.00 | -416,707,000.00 | -157,160,000.00 | 58,501,000.00 | -5,592,000.00 | 388,000.00 | ||||||
| EBITDA | |||||||||||||||||||
| EBITDA | -75,215,000.00 | -613,215,000.00 | -716,278,000.00 | -833,335,000.00 | -909,400,000.00 | -1,082,389,000.00 | -1,225,242,000.00 | -901,535,000.00 | -2,082,295,000.00 | -1,601,058,000.00 | -1,141,146,000.00 | -1,929,691,000.00 | -1,686,793,000.00 | ||||||
| EBITDA ratio | (-0.19%) | (-512.99%) | (-24.61%) | (-6.87%) | (-4.73%) | (-4.73%) | (-7.27%) | (-0.41%) | (-5.46%) | (-2.32%) | (-1.19%) | (-30.61%) | (-53.75%) | ||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | -100,513,000.00 | -633,193,000.00 | -737,106,000.00 | -854,701,000.00 | -928,344,000.00 | -1,087,185,000.00 | -1,230,105,000.00 | -908,593,000.00 | -2,091,359,000.00 | -1,611,714,000.00 | -1,146,005,000.00 | -1,935,578,000.00 | -1,681,015,000.00 | ||||||
| Income Before Tax Ratio | (-0.25%) | (-536.60%) | (-25.60%) | (-7.05%) | (-5.21%) | (-4.74%) | (-7.30%) | (-0.70%) | (-6.66%) | (-2.51%) | (-1.17%) | (-30.70%) | (-53.56%) | ||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 2,315,000.00 | 2,359,000.00 | 1,892,000.00 | 2,588,000.00 | 3,052,000.00 | 3,518,000.00 | 3,740,000.00 | 3,752,000.00 | 3,727,000.00 | 3,725,000.00 | 2,932,000.00 | 2,926,000.00 | 3,763,000.00 | ||||||
| Net Income | |||||||||||||||||||
| Net Income | -102,829,000.00
+0% |
-635,553,000.00
+518% |
-738,999,000.00
+16% |
-857,290,000.00
+16% |
-931,397,000.00
+9% |
-1,090,703,000.00
+17% |
-1,233,846,000.00
+13% |
-912,345,000.00
-26% |
-2,095,086,000.00
+130% |
-1,615,439,000.00
-23% |
-1,148,937,000.00
-29% |
-1,938,505,000.00
+69% |
-1,684,778,000.00
-13% |
||||||
| Net Income Ratio | (-0.26%) | (-538.60%) | (-25.66%) | (-7.07%) | (-5.22%) | (-4.76%) | (-7.32%) | (-0.70%) | (-6.67%) | (-2.51%) | (-1.18%) | (-30.75%) | (-53.68%) | ||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | -16.83 | -94.33 | -80.55 | -93.35 | -101.18 | -106.23 | -104.55 | -65.55 | -145.58 | -95.50 | -66.31 | -108.92 | -77.17 | ||||||
| Diluted EPS | -16.83 | -94.33 | -80.55 | -93.35 | -101.18 | -106.23 | -104.55 | -65.55 | -145.58 | -95.50 | -66.31 | -108.92 | -77.17 | ||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 6,108,182.00 | 6,737,371.00 | 9,174,376.00 | 9,183,633.00 | 9,205,637.00 | 10,267,098.00 | 11,801,825.00 | 13,917,336.00 | 14,391,621.00 | 16,915,148.00 | 17,327,407.00 | 17,797,360.00 | 21,831,246.00 | ||||||
| Diluted Share Outstanding | 6,108,182.00 | 6,737,371.00 | 9,174,376.00 | 9,183,633.00 | 9,205,637.00 | 10,267,098.00 | 11,801,825.00 | 13,917,336.00 | 14,391,621.00 | 16,915,148.00 | 17,327,407.00 | 17,797,360.00 | 21,831,246.00 | ||||||